Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782
Titel:
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782
Auteur:
Bar, Jair Esteban, Emilio Rodríguez-Abreu, Delvys Aix, Santiago Ponce Szalai, Zsuzsanna Felip, Enriqueta Gottfried, Maya Provencio, Mariano Robinson, Andrew Fülöp, Andrea Rao, Suman Bannur Camidge, D. Ross Speranza, Giovanna Townson, Steven M. Kobie, Julie Ayers, Mark Dettman, E.J. Hunkapiller, Nathan McDaniel, Robert Jung, Byoungsok Burkhardt, David Mauntz, Ruth Csőszi, Tibor
Verschenen in:
Lung cancer
Paginering:
Jaargang 190 () nr. C pagina's p.
Jaar:
2024
Inhoud:
Uitgever:
Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, The Author(s)